475 results on '"Gilks, C. Blake"'
Search Results
2. VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology
3. Molecular pathology of endometrial cancer: recent advances in classification, prognostication, and management
4. High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining
5. Genomic characterization of DICER1-associated neoplasms uncovers molecular classes
6. p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?
7. Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
8. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
9. Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images
10. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
11. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva
12. Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes.
13. The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
14. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs
15. Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
16. Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes
17. Ovarian borderline tumours and carcinomas: an update
18. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
19. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines
20. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
21. Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
22. Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)
23. Learning generalizable AI models for multi-center histopathology image classification.
24. PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi.
25. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns
26. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
27. Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
28. Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
29. Therapeutic options for mucinous ovarian carcinoma
30. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique
31. Endometrial Carcinoma Molecular Subtype Correlates With the Presence of Lymph Node Metastases
32. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status
33. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
34. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
35. Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies
36. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma
37. Histotype classification of ovarian carcinoma: A comparison of approaches
38. TERT promoter mutation in adult granulosa cell tumor of the ovary
39. Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging
40. Synchronous tumours of the female reproductive tract
41. FIGO 2023 endometrial cancer staging: too much, too soon?
42. Mesonephric‐like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
43. Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
44. Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma
45. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
46. The Gfi-1 Protooncoprotein Represses Bax Expression and Inhibits T-Cell Death
47. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
48. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes
49. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
50. Rare cancers: a sea of opportunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.